New Blood-Filtering strategy aims to save lives from weed killer poisoning

NCT ID NCT07234383

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests whether starting a specific type of blood filtering (hemodiafiltration) immediately after a standard blood-cleaning treatment (hemoperfusion) can improve survival in people with severe diquat poisoning. Diquat is a herbicide that can cause rapid kidney failure and death. The study will enroll 24 adults with high levels of diquat in their blood. Researchers will track how many survive and how long they live, aiming to see if this faster approach is safe and promising enough for larger studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Continuous veno-venous hemodiafiltration (a type of blood filtering procedure)

What this could lead to

If successful, this could establish a faster, more effective way to filter the blood after diquat poisoning, potentially reducing deaths.

What could go wrong

This is a very early, small (24 people) single-arm trial with no comparison group. The approach may not improve outcomes and carries risks from the procedure itself, like bleeding or infection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIQUAT POISONING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

paraquat poisoning

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.